Trial intelligence / Profile preview

Insulin nasal drip for prevention of postoperative delirium after hip fracture surgery in older adults

ChiCTR2400085627Phase 4Not yet recruiting

Sponsor
Fuyang People's Hospital
Start
Jun 2024
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised trial in postoperative delirium (POD) comparing Insulin nasal drip with Normal saline nasal drip (placebo) (2 arms). Primary endpoint: Incidence of postoperative delirium. Planned start Jun 2024; status: not yet recruiting.

02

Drugs

human insulin
03

Conditions

postoperative delirium (POD)

Beyond the preview

Go deeper on ChiCTR2400085627.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400085627.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call